tradingkey.logo

Metagenomi Inc

MGX
詳細チャートを表示

2.050USD

-0.090-4.21%
終値 09/19, 16:00ET15分遅れの株価
76.94M時価総額
損失額直近12ヶ月PER

Metagenomi Inc

2.050

-0.090-4.21%
Intraday
1m
30m
1h
D
W
M
D

本日

-4.21%

5日間

+10.22%

1ヶ月

+12.02%

6ヶ月

+19.88%

年初来

-43.21%

1年間

-22.05%

詳細チャートを表示

TradingKey 株式スコア

これ以上のデータはありません

ニュース

最新情報をお待ちください...

財務指標

EPS

データなし

総売上高

データなし

企業名

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed an expansive and modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. Its platform enables it to rapidly and effectively find, screen, and select tools with the highest targetability, specificity, and efficiency in order to develop them into genetic medicine.
企業コードMGX
企業名Metagenomi Inc
最高経営責任者「CEO」Dr. Brian C. Thomas, Ph.D.
ウェブサイトhttps://metagenomi.co/
KeyAI